VERDE BIO HOLDINGS, INC. (APHD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue TTM

0 15K 30K 45K Q4 '11: 6.7K Q1 '12: 4.3K Q2 '12: 2.8K Q3 '12: 2.2K Q4 '12: 1.5K Q1 '13: 1.4K Q2 '13: 1.1K Q3 '13: 913 Q4 '13: 689 Q1 '14: 622 Q2 '14: 669 Q3 '14: 606 Q4 '14: 485 Q1 '15: 543 Q2 '15: 374 Q3 '15: 252 Q4 '15: 258 Q4 '18: 41.9K Q1 '19: 30.8K Q2 '19: 13.9K Q3 '19: 0 Q4 '19: 0 Q4 '11 Q3 '12 Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q1 '19 Q4 '19

Gross Profit TTM

0 7K 14K 21K Q4 '18: 18.5K Q1 '19: 12.4K Q2 '19: 5.3K Q3 '19: 0 Q4 '19: 0 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Income TTM

-6M -4M -2M 0 2M 4M 6M Q4 '12: -151.5K Q1 '13: -134.6K Q2 '13: -127.5K Q3 '13: -128.6K Q4 '13: -160.8K Q1 '14: -204.9K Q2 '14: -223.3K Q3 '14: -176.7K Q4 '14: -134.5K Q1 '15: -109.7K Q2 '15: -228.1K Q3 '15: -215.6K Q4 '15: -233.5K Q1 '16: -211.4K Q2 '16: -93.2K Q3 '16: -208.8K Q4 '16: -196.3K Q1 '17: -266.6K Q2 '17: -337.6K Q1 '18: -549.1K Q2 '18: -548.5K Q3 '18: -509.5K Q4 '18: -450.8K Q1 '19: -297.2K Q2 '19: -201.6K Q3 '19: -107.1K Q4 '19: -37.1K Q1 '20: -60.6K Q2 '20: -89K Q3 '20: -143.5K Q4 '20: -259.2K Q1 '21: -557K Q2 '21: -619.4K Q3 '21: -667.5K Q4 '21: -3M Q1 '22: -3.3M Q2 '22: -4.8M Q3 '22: -5.2M Q4 '22: -3.2M Q1 '23: -3.2M Q2 '23: -1.7M Q3 '23: -1.7M Q4 '23: -1.6M Q1 '24: -1.3M Q2 '24: -1.4M Q3 '24: -1.4M Q3 '13 Q1 '15 Q3 '16 Q3 '18 Q1 '20 Q3 '21 Q1 '23 Q3 '24

Net Income TTM

-6M -4M -2M 0 2M 4M 6M Q4 '11: -127.3K Q1 '12: -127.1K Q2 '12: -105.7K Q3 '12: -136.5K Q4 '12: -145.5K Q1 '13: -89.6K Q2 '13: -82.6K Q3 '13: -83.7K Q4 '13: -120.8K Q1 '14: -207.9K Q2 '14: -467.7K Q3 '14: -481.5K Q4 '14: -404.8K Q1 '15: -437.2K Q2 '15: -446K Q3 '15: -682.5K Q4 '15: -797.9K Q1 '16: -526.2K Q2 '16: -592.5K Q3 '16: -827.7K Q4 '16: -125.6K Q1 '17: -631.5K Q2 '17: -592.5K Q1 '18: -1.9M Q2 '18: -2M Q3 '18: -2.1M Q4 '18: -1.5M Q1 '19: -1.1M Q2 '19: -826.7K Q3 '19: -709.9K Q4 '19: -537.1K Q1 '20: -1.2M Q2 '20: -1.4M Q3 '20: -1.7M Q4 '20: -1.6M Q1 '21: -2.1M Q2 '21: -1.5M Q3 '21: -1.2M Q4 '21: -3.3M Q1 '22: -2.4M Q2 '22: -4.3M Q3 '22: -5M Q4 '22: -2.8M Q1 '23: -3.6M Q2 '23: -2.1M Q3 '23: -1.8M Q4 '23: -1.9M Q1 '24: -1.5M Q2 '24: -1.7M Q3 '24: -2.7M Q4 '11 Q3 '13 Q2 '15 Q1 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24

Cost of Revenue TTM

0 9K 18K 27K Q1 '18: 21.5K Q2 '18: 20K Q3 '18: 24.7K Q4 '18: 23.3K Q1 '19: 18.3K Q2 '19: 8.6K Q3 '19: 0 Q4 '19: 0 Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q4 '11: -84.3K Q1 '12: -81.4K Q2 '12: -75.5K Q3 '12: -51.8K Q4 '12: -33.2K Q1 '13: -14.5K Q2 '13: -6.1K Q3 '13: -1.2K Q4 '13: -3.3K Q1 '14: -33.6K Q2 '14: -32.3K Q3 '14: -54K Q4 '14: -51.7K Q1 '15: -50.5K Q2 '15: -67.9K Q3 '15: -52.4K Q4 '15: -61.6K Q1 '16: -33.8K Q2 '16: -27.3K Q4 '17: -265.7K Q1 '18: -293.8K Q2 '18: -303.1K Q3 '18: -293.3K Q4 '18: -225K Q1 '19: -134.8K Q2 '19: -62.9K Q3 '19: -19.1K Q4 '19: -16.4K Q1 '20: -21K Q2 '20: -51.2K Q3 '20: -92.5K Q4 '20: -177.8K Q1 '21: -230.2K Q2 '21: -279.1K Q3 '21: -309.3K Q4 '21: -685.2K Q1 '22: -1.2M Q2 '22: -1.4M Q3 '22: -1.6M Q4 '22: -1.2M Q1 '23: -964.2K Q2 '23: -718K Q3 '23: -725.9K Q4 '23: -872.2K Q1 '24: -833.7K Q2 '24: -1.1M Q3 '24: -1.1M Q4 '12 Q2 '14 Q4 '15 Q3 '18 Q1 '20 Q3 '21 Q1 '23 Q3 '24

Free Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '11: -86.1K Q1 '12: -81.4K Q2 '12: -75.5K Q3 '12: -51.8K Q4 '12: -33.2K Q1 '13: -14.5K Q4 '22: -4M Q1 '23: -3.7M Q2 '23: -957.8K Q3 '23: -995.8K Q4 '23: -879.2K Q1 '24: -833.7K Q2 '24: -1.1M Q4 '11 Q2 '12 Q4 '12 Q4 '22 Q2 '23 Q4 '23 Q2 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q1 '11: 5.9M Q1 '12: 6.3M Q1 '15: 139.5K Q1 '16: 46.3M Q1 '17: 35.9M Q1 '18: 3.3M Q2 '18: 7.7M Q3 '18: 14.7M Q1 '19: 896.6M Q2 '19: 1.3M Q3 '19: 1.1M Q1 '20: 1.1M Q2 '20: 1.5M Q3 '20: 1.7M Q2 '21: 43M Q3 '21: 51M Q2 '22: 1.2B Q3 '23: 1.4B Q3 '24: 1.9B Q1 '11 Q1 '16 Q2 '18 Q2 '19 Q2 '20 Q3 '21 Q3 '24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '11: -0.03 Q1 '12: -0.02 Q2 '12: -0.01 Q3 '12: -0.01 Q4 '12: -0.01 Q1 '13: -0.01 Q2 '13: -0.01 Q3 '13: -0.01 Q4 '13: -0.01 Q1 '14: -0.02 Q2 '14: -0.04 Q3 '14: -6.82 Q4 '14: -6.65 Q1 '15: -7.31 Q2 '15: -8.18 Q3 '15: -1.66 Q4 '15: -1.00 Q1 '16: -0.33 Q2 '16: 0.38 Q3 '16: 0.61 Q1 '18: -1.49 Q2 '18: -1.53 Q3 '18: -1.51 Q4 '18: -0.12 Q1 '20: -1.07 Q2 '20: -1.14 Q3 '20: -1.28 Q4 '20: -1.06 Q1 '21: -0.74 Q2 '21: -0.56 Q3 '21: -0.34 Q4 '21: -0.03 Q1 '22: 0.01 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q1 '18 Q2 '20 Q3 '21 Q4 '22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.